Osimertinib as a second-line treatment for EGFR-mutated non-small cell lung cancer: the experience of a Pulmonology department Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020
Efficacy and safety of nivolumab in routine NSCLC treatment – an observational study in 5 lung cancer centers in Berlin, Germany Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies Year: 2017
Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT) Source: Virtual Congress 2021 – Innovation in thoracic surgery Year: 2021
The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening Source: Eur Respir J, 54 (2) 1802221; 10.1183/13993003.02221-2018 Year: 2019
Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care? Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Rapid access lung cancer clinics Source: Eur Respir J 2002; 20: Suppl. 38, 77s Year: 2002
Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service Source: International Congress 2018 – Genetics in chronic pulmonary diseases Year: 2018
Lung cancer treatment strategies in a district general hospital Source: Eur Respir J 2006; 28: Suppl. 50, 750s Year: 2006
Lung cancer treatment strategies in district general hospital Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology Year: 2007
Impact of a lung cancer screening programme on a London hospital service Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021
Innovative local therapies in lung cancer Source: International Congress 2018 – PG11 Modern approaches in lung cancer diagnostics and therapy Year: 2018
Clinical management of lung cancer in France: a national survey Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001
Patient and doctor delays in the diagnosis and treatment of non-small cell lung cancer in Turkey Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013
The cost of lung cancer in Turkey Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004
The impact of specialist lung cancer clinics on government targets in patients referred with suspected lung cancer in the University Hospital of North Staffordshire, UK Source: Eur Respir J 2007; 30: Suppl. 51, 666s Year: 2007
Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Chemotherapy for lung cancer in Scotland: a national survey Source: Eur Respir J 2002; 20: Suppl. 38, 465s Year: 2002
Programme CC6 New treatment approaches in non-small cell lung cancer Source: International Congress 2016 – CC6 New treatment approaches in non-small cell lung cancer Year: 2016
New chemotherapeutic agents Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=259 Year: 2001